Claire Roddie

29PUBLICATIONS
131CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyLiquid biopsiesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jul 01, 2026
CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis.

|Jun 04, 2026
CAR T-cell Kinetics, Persistence, and Clinical Outcomes in Adult Patients with Relapsed/Refractory B-cell ALL Treated with Obecabtagene Autoleucel in the FELIX Study.

|Mar 28, 2026
Immunotherapies for Breast Cancer: From Checkpoint Inhibition to Emerging Cellular Therapies.

Ismini Tsagkaraki, Isaac Gannon, Alexandros Rampotas

|Mar 27, 2026
Early PET response predicts the risk of relapse after 2L axi-cel in large B-cell lymphoma.

Andrea Kuhnl, Amy A Kirkwood, Michael Northend

|Feb 26, 2026
Outcomes of second-line axicabtagene ciloleucel for large B-cell lymphoma in the UK.

Andrea Kuhnl, Amy A Kirkwood, Michael Northend

|Jul 11, 2025
Matched donor allogeneic CAR-T for adult B-ALL: toxicity, efficacy, repeat dosing, and the importance of lymphodepletion.

Claire Roddie, Juliana Dias, Maeve A O'Reilly

Pageof 5

Frequent Collaborators

8 joint publications

Maeve O'Reilly

6 joint publications

Andrea Kuhnl

5 joint publications

Adrian Bloor

5 joint publications

Robin Sanderson